Paul Mcnaulty (former US deputy attorney general)
Access to new markets, especially a complex one, such as the EU is challenging for any medicine or medical device manufacturer.
Versatile & critical aspects should be proactively assessed, and adequately implemented to ensure full market compliance.
You can rely on us as experienced, regulatory compliance experts.
If you have a medicinal product eligible for EU National (NP), Decentralized (DCP), or Mutual Recognition (MRP) Procedure in one or more Member States (MS), be aware that there are countries with strong local requirements, such as Croatia, France, Hungary, Poland, or Slovakia. But, we have a strong local network and can liaise you with all these authorities.
The U.S. agent must either reside in the U.S. or maintain a place of business in the U.S.
The responsibilities of the U.S. agent are limited and include: assisting the FDA in communications with foreign establishments & assisting the FDA in scheduling inspections of foreign establishments. Our extended team members in the US can support you.
We can be your guide through complex global regulatory, quality & sustainability frameworks and support you in reaching your targets.
Copyright © 2024 Indaea OÜ - All Rights Reserved.